Michael B. Elefante’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$269K Sell
9,085
-343
-4% -$9.84K 0.29% 66
2014
Q3
$265K Sell
9,428
-527
-5% -$14.8K 0.11% 83
2014
Q2
$280K Sell
9,955
-174
-2% -$4.96K 0.12% 83
2014
Q1
$309K Sell
10,129
-1,775
-15% -$52.9K 0.13% 80
2013
Q4
$346K Buy
11,904
+501
+4% +$14.6K 0.16% 74
2013
Q3
$311K Buy
11,403
+3,818
+50% +$104K 0.16% 71
2013
Q2
$202K Buy
+7,585
New +$210K 0.11% 97

Other funds holding PFE

Michael B. Elefante's PFE Position: Q4 2014 in Review

Michael B. Elefante reduced its Pfizer (PFE) stake by 3.6% in Q4 2014, selling an estimated $9.84K and leaving 9,085 shares worth $269K. The position accounts for 0.29% of the portfolio, ranked #66.

Michael B. Elefante first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $346K in Q4 2013. 1,861 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Michael B. Elefante held 9,085 shares of Pfizer worth $269K as of Q4 2014.
  • Michael B. Elefante sold 343 Pfizer shares in Q4 2014, an estimated $9.84K.
  • Pfizer made up 0.29% of Michael B. Elefante's portfolio in Q4 2014, its #66 holding.
  • Michael B. Elefante first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Michael B. Elefante's Pfizer position peaked at $346K in Q4 2013.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.